Review Article
Volume 10 Issue 2 - 2021
A Critical Discussion of the Clinical Management of Dietary Supplementation in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder
Marios Dimitrios Chatzinikolaou1* and Vasiliki Apeiranthitou2
1Department of Psychology, University of Derby, United Kingdom
2Division of Psychology and Language Sciences, University College London and Anna Freud National Centre for Children and Families, United Kingdom
*Corresponding Author: Marios Dimitrios Chatzinikolaou, Undergraduate Applied Psychology Student, Department of Psychology, University of Derby, United Kingdom.
Received: December 10, 2020; Published: January 30, 2021


Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) are both classified as neurodevelopmental disorders, affecting primarily young children and adolescents, stemming from biological/genetic and environmental origins that negatively influence neurobiological structures and leading to gastrointestinal discomforts. More precisely, toxins produced by pathogenic microorganisms’ overgrowth, unnecessary employment of antibiotics, abnormalities in the activity of carbohydrate digestive enzymes and gut’s mucosal lining disruptions result in alterations in children’s neurological functioning. Central nervous system alterations adversely affect brain maturation, social interactions, and cognitive abilities. In this respect, dietary supplementations such as omega-3 and omega-6 long-chain polyunsaturated fatty acids and/or vitamins can be effectuated, potentially increasing the effectiveness of pharmacological medications. However, research findings divulge an unspecified consensus concerning optimal supplementation duration, exact dosages, consistent utilization of outcome measures, adherence to supplements, and their longterm behavioral and health effects. In addition, dietary supplements do not always enable for corrections of children’s micronutrient deficiencies, contributing to excessive intake. Thus, it can be speculated that they cannot be provided solitarily since they depict developmental insensitivities in addressing all nutritional needs of Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder individuals. Accordingly, each individual’s developmental needs and entire dietary patterns should be carefully considered for the elimination of comorbid health conditions. In conjunction with the development and validation of universally accepted dietary plan, this shall allow for the construction of a holistic and multidisciplinary approach to dietary treatment schemes that can fully benefit these populations and are especially adapted to their needs. Future research should further explore gluten/casein-free and other restrictive diets, along with the clarification of effective randomized controlled trials.

Keywords: Attention-Deficit/Hyperactivity Disorder; Autism Spectrum Disorder; Central Nervous System; Developmental Needs; Dietary Supplements; Neurological Functioning


  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Dsm-5®). American Psychiatric Publication (2013).
  2. Doernberg, Ellen and Eric Hollander. "Neurodevelopmental Disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11”. CNS spectrums4 (2016): 295-299.
  3. Adams James B., et al. "Comprehensive nutritional and dietary intervention for autism spectrum disorder—A randomized, controlled 12-month trial”. Nutrients3 (2018): 369.
  4. Karhu Elisa., et al. "Nutritional interventions for autism spectrum disorder”. Nutrition Reviews7 (2020): 515-531.
  5. Sathe Nila., et al. "Nutritional and dietary interventions for autism spectrum disorder: a systematic review”. Pediatrics6 (2017): e20170346.
  6. Stewart Patricia A., et al. "Dietary supplementation in children with autism spectrum disorders: common, insufficient, and excessive”. Journal of the Academy of Nutrition and Dietetics8 (2015): 1237-1248.
  7. Kortekaas-Rijlaarsdam Anne Fleur., et al. "Does methylphenidate improve academic performance? A systematic review and meta-analysis”. European Child and Adolescent Psychiatry 2 (2019): 155-164.
  8. Ramaswami Gokul and Daniel H Geschwind. "Genetics of autism spectrum disorder”. Handbook of Clinical Neurology 147 (2018): 321-329.
  9. Grimm Oliver., et al. "Genetics of ADHD: What Should the Clinician Know?”. Current Psychiatry Reports 4 (2020): 1-8.
  10. Hoogman Martine., et al. "Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure”. Human Brain Mapping (2020).
  11. Iovene Maria Rosaria., et al. "Intestinal dysbiosis and yeast isolation in stool of subjects with autism spectrum disorders”. Mycopathologia3-4 (2017): 349-363.
  12. Felice Valeria D and Siobhain M O'Mahony. "The microbiome and disorders of the central nervous system”. Pharmacology Biochemistry and Behavior 160 (2017): 1-13.
  13. Aarts Esther., et al. "Gut microbiome in ADHD and its relation to neural reward anticipation”. PloS one9 (2017): e0183509.
  14. Szopinska-Tokov Joanna., et al. "Investigating the gut microbiota composition of individuals with attention-deficit/hyperactivity disorder and association with symptoms”. Microorganisms3 (2020): 406.
  15. Murphy Clodagh M., et al. "Abnormal functional activation and maturation of fronto-striato-temporal and cerebellar regions during sustained attention in autism spectrum disorder”. American Journal of Psychiatry10 (2014): 1107-1116.
  16. Whiteley Paul and Paul Shattock. "Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention”. Expert Opinion on Therapeutic Targets2 (2002): 175-183.
  17. Bull-Larsen Stephanie and M Hasan Mohajeri. "The potential influence of the bacterial microbiome on the development and progression of ADHD”. Nutrients11 (2019): 2805.
  18. Sandgren Anna M and Robert JM Brummer. "ADHD-originating in the gut? The emergence of a new explanatory model”. Medical Hypotheses 120 (2018): 135-145.
  19. Cieślińska Anna., et al. "Influence of candidate polymorphisms on the dipeptidyl peptidase IV and μ-opioid receptor genes expression in aspect of the β-casomorphin-7 modulation functions in autism”. Peptides 65 (2015): 6-11.
  20. Reichow Brian and Erin E Barton. "Evidence‐based psychosocial interventions for individuals with autism spectrum disorders”. Handbook of Autism and Pervasive Developmental Disorders, Fourth Edition (2014).
  21. Sathe Nila., et al. "Nutritional and dietary interventions for autism spectrum disorder: a systematic review”. Pediatrics 6 (2017).
  22. Marí-Bauset Salvador., et al. "Nutritional impact of a gluten-free casein-free diet in children with autism spectrum disorder”. Journal of Autism and Developmental Disorders2 (2016): 673-684.
  23. Mazahery Hajar., et al. "A randomised-controlled trial of vitamin d and omega-3 long chain polyunsaturated fatty acids in the treatment of core symptoms of autism spectrum disorder in children”. Journal of Autism and Developmental Disorders5 (2019): 1778-1794.
  24. Saad Khaled., et al. "Retracted: Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder”. Journal of Child Psychology and Psychiatry1 (2018): 20-29.
  25. Mankad Deepali., et al. "A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism”. Molecular Autism1 (2015): 18.
  26. Bent Stephen., et al. "Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism”. Journal of the American Academy of Child and Adolescent Psychiatry6 (2014): 658-666.
  27. González-Domenech Pablo José., et al. "Influence of a gluten-free, casein-free diet on behavioral disturbances in children and adolescents diagnosed with autism spectrum disorder: A 3-month follow-up pilot study”. Journal of Mental Health Research in Intellectual Disabilities 3-4 (2019): 256-272.
  28. Boone Kelly M., et al. "Omega-3 and-6 fatty acid supplementation and sensory processing in toddlers with ASD symptomology born preterm: a randomized controlled trial”. Early Human Development 115 (2017): 64-70.
  29. Sheppard Kelly W., et al. "Effect of omega-3 and-6 supplementation on language in preterm toddlers exhibiting autism spectrum disorder symptoms”. Journal of Autism and Developmental Disorders 11 (2017): 3358-3369.
  30. Van der Wurff., et al. "A review of recruitment, adherence and drop-out rates in omega-3 polyunsaturated fatty acid supplementation trials in children and adolescents”. Nutrients5 (2017): 474.
  31. Whiteley Paul., et al. "Gluten-and casein-free dietary intervention for autism spectrum conditions”. Frontiers in Human Neuroscience 6 (2013): 344.
  32. Bandini Linda G., et al. "Food selectivity in children with autism spectrum disorders and typically developing children”. The Journal of Pediatrics2 (2010): 259-264.
  33. Gogou Maria and George Kolios. "The effect of dietary supplements on clinical aspects of autism spectrum disorder: A systematic review of the literature”. Brain and Development8 (2017): 656-664.
  34. Faltinsen Erlend., et al. "Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look”. BMJ Evidence-Based Medicine3 (2019): 99-102.
  35. Lange Klaus W. "Dietary factors in the etiology and therapy of attention deficit/hyperactivity disorder”. Current Opinion in Clinical Nutrition and Metabolic Care6 (2017): 464-469.
  36. Hemamy Mostafa., et al. "Effect of Vitamin D and magnesium supplementation on behavior problems in children with attention-deficit hyperactivity disorder”. International Journal of Preventive Medicine 11 (2020).
  37. Richardson Alexandra J and Paul Montgomery. "The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder”. Pediatrics5 (2005): 1360-1366.
  38. Pelsser Lidy M., et al. "Diet and ADHD, reviewing the evidence: a systematic review of meta-analyses of double-blind placebo-controlled trials evaluating the efficacy of diet interventions on the behavior of children with ADHD”. PloS one 1 (2017): e0169277.
  39. Cornu Catherine., et al. "A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms”. European Child and Adolescent Psychiatry3 (2018): 377-384.
  40. Lange Klaus W. "Micronutrients and diets in the treatment of attention-deficit/hyperactivity disorder: chances and pitfalls”. Frontiers in Psychiatry 11 (2020).
  41. LaChance Laura., et al. "Omega-6 to omega-3 fatty acid ratio in patients with ADHD: a meta-analysis”. Journal of the Canadian Academy of Child and Adolescent Psychiatry2 (2016): 87.
  42. Parletta Natalie., et al. "Omega-3 and omega-6 polyunsaturated fatty acid levels and correlations with symptoms in children with attention deficit hyperactivity disorder, autistic spectrum disorder and typically developing controls”. PLoS One5 (2016): e0156432.
  43. Luo Yuyang., et al. "A review of heterogeneity in attention deficit/hyperactivity disorder (ADHD)”. Frontiers in Human Neuroscience 13 (2019): 42.
  44. Lange Klaus W., et al. "Are there serious adverse effects of omega-3 polyunsaturated fatty acid supplements?”. Journal of Food Bioactives 7 (2019).
  45. López-Vicente Mónica., et al. "Prenatal omega-6: omega-3 ratio and attention deficit and hyperactivity disorder symptoms”. The Journal of Pediatrics 209 (2019): 204-211.
  46. Ríos-Hernández Alejandra., et al. "The Mediterranean diet and ADHD in children and adolescents”. Pediatrics2 (2017).
  47. Shareghfarid Elham., et al. "Empirically derived dietary patterns and food groups intake in relation with Attention Deficit/Hyperactivity Disorder (ADHD): A systematic review and meta-analysis”. Clinical Nutrition ESPEN (2020).
  48. Piwowarczyk Anna., et al. "Gluten-and casein-free diet and autism spectrum disorders in children: a systematic review”. European Journal of Nutrition2 (2018): 433-440.
  49. El-Rashidy Omnia., et al. "Ketogenic diet versus gluten free casein free diet in autistic children: a case-control study”. Metabolic Brain Disease6 (2017): 1935-1941.
  50. Ghalichi Faezeh., et al. "Effect of gluten free diet on gastrointestinal and behavioral indices for children with autism spectrum disorders: a randomized clinical trial”. World Journal of Pediatrics4 (2016): 436-442.
Citation: Marios Dimitrios Chatzinikolaou and Vasiliki Apeiranthitou. “A Critical Discussion of the Clinical Management of Dietary Supplementation in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder”. EC Psychology and Psychiatry 10.2 (2021): 74-80.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

January Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the January issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 07, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to